Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8025 USD | +0.19% | -18.12% | -33.12% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.65M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.1
x | P/E ratio 2024 * |
-0.11
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Eloxx Pharmaceuticals, Inc.
1 day | +0.19% | ||
1 week | -18.12% | ||
Current month | -19.75% | ||
1 month | -11.91% | ||
3 months | -27.70% | ||
6 months | -51.95% | ||
Current year | -33.12% |
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.8025 | +0.19% | 1,669 |
24-04-19 | 0.801 | -14.79% | 45,853 |
24-04-18 | 0.94 | -2.34% | 8,256 |
24-04-17 | 0.9625 | -2.52% | 10,806 |
24-04-16 | 0.9874 | +0.75% | 4,108 |
Delayed Quote OTC Markets, April 22, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.12% | 2.65M | |
+2.49% | 96.73B | |
-1.86% | 21.31B | |
-16.61% | 21.21B | |
-5.80% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- ELOX Stock